Published in Blood Weekly, May 10th, 2001
The identification of a biological marker early in life and before the onset of symptoms could lead to earlier and more definitive diagnoses, better clinical definitions, and the discovery of interventional therapies for the disorders.
Investigators at the U.S. National Institute of Neurological Disorders and Stroke (NINDS), the March of Dimes/California Birth Defects Monitoring Program, and the MIND Institute at the University of California, Davis, collaborated on the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.